{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:06Z","timestamp":1786993206619,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","jpedsurg.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpedsurg.2024.02.014","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T01:55:49Z","timestamp":1708912549000},"page":"1582-1590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proliferative Effects of Mesenchymal Stromal Cells on Neuroblastoma Cell Lines: Are They Tumor Promoting or Tumor Inhibiting?"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-6129","authenticated-orcid":false,"given":"Kathleen","family":"Doyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd-Elrahman","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarsini","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpedsurg.2024.02.014_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/scd.2020.0142","article-title":"Mesenchymal stromal cells in neuroblastoma: exploring crosstalk and therapeutic implications","volume":"30","author":"Hochheuser","year":"2021","journal-title":"Stem Cell Dev"},{"issue":"11","key":"10.1016\/j.jpedsurg.2024.02.014_bib2","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1002\/jcp.30384","article-title":"The quest to develop an effective therapy for neuroblastoma","volume":"236","author":"Bhoopathi","year":"2021","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fbioe.2020.00043","article-title":"Therapeutic potential of mesenchymal stem cells for cancer therapy","volume":"8","author":"Hmadcha","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.02.014_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/jpm11030161","article-title":"The potential of mesenchymal stromal cells in neuroblastoma therapy for delivery of anti-cancer agents and hematopoietic recovery","volume":"11","author":"Hochheuser","year":"2021","journal-title":"J\u00a0Personalized Med"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.02.014_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jpedsurg.2024.02.014_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039119","article-title":"Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer","volume":"7","author":"Zheng","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jpedsurg.2024.02.014_bib7","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.02.014_bib8","first-page":"35","article-title":"Engineered human mesenchymal stem cells for neuroblastoma therapeutics","volume":"42","author":"Nieddu","year":"2019","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.jpedsurg.2024.02.014_bib9","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.21873\/anticanres.14577","article-title":"Mesenchymal stem cells combined with IFN\u03b3 induce apoptosis of breast cancer cells partially through TRAIL","volume":"40","author":"Yenilmez","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.canlet.2018.10.017","article-title":"Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-\u03b2 and TRAIL and suppress the growth of H460 human lung cancer cells","volume":"440\u2013441","author":"Jung","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.02.014_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4252\/wjsc.v2.i1.5","article-title":"The bad and the good of mesenchymal stem cells in cancer: boosters of tumor growth and vehicles for targeted delivery of anticancer agents","volume":"2","author":"Galderisi","year":"2010","journal-title":"World J Stem Cell"},{"issue":"12","key":"10.1016\/j.jpedsurg.2024.02.014_bib12","doi-asserted-by":"crossref","first-page":"30015","DOI":"10.3390\/ijms161226215","article-title":"Mesenchymal stem cell-mediated effects of tumor support or suppression","volume":"16","author":"Rhee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","article-title":"The multifaceted role of mesenchymal stem cells in cancer","volume":"60","author":"Timaner","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"22","key":"10.1016\/j.jpedsurg.2024.02.014_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212429","article-title":"Mesenchymal stem cell: a friend or foe in anti-tumor immunity","volume":"22","author":"Harrell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fbioe.2020.00748","article-title":"Recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of cancer","volume":"8","author":"Babajani","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"10.1016\/j.jpedsurg.2024.02.014_bib16","first-page":"556","article-title":"Differentiation induction and proliferation inhibition by A cell-free approach for delivery of exogenous miRNAs to neuroblastoma cells using mesenchymal stem cells","volume":"22","author":"Sharif","year":"2021","journal-title":"Cell J"},{"issue":"10","key":"10.1016\/j.jpedsurg.2024.02.014_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202200054","article-title":"Placenta-derived mesenchymal stem cells for treatment of diseases: a clinically relevant source","volume":"5","author":"Moonshi","year":"2022","journal-title":"Advanced Therapeutics"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.02.014_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/ol.2012.772","article-title":"Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model","volume":"4","author":"Chen","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib19","article-title":"Endothelial progenitor cell migration-enhancing factors in the secretome of placental-derived mesenchymal stem cells","volume":"2016","author":"Kamprom","year":"2016","journal-title":"Stem Cell Int"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.02.014_bib20","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1096\/fj.201800972R","article-title":"Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes","volume":"33","author":"Kumar","year":"2019","journal-title":"Faseb J"},{"issue":"6","key":"10.1016\/j.jpedsurg.2024.02.014_bib21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcyt.2017.03.003","article-title":"Manufacture and preparation of human placenta-derived mesenchymal stromal cells for local tissue delivery","volume":"19","author":"Lankford","year":"2017","journal-title":"Cytotherapy"},{"issue":"17","key":"10.1016\/j.jpedsurg.2024.02.014_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713511","article-title":"The dual role of mesenchymal stem cells in cancer pathophysiology: pro-tumorigenic effects versus therapeutic potential","volume":"24","author":"Slama","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/path.5357","article-title":"Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression","volume":"250","author":"Galland","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-023-10606-1","article-title":"Exosomal miR-99b-5p secreted from mesenchymal stem cells can retard the progression of colorectal cancer by targeting FGFR3","author":"Ning","year":"2023","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.02.014_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.02.014_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/scd.2007.0181","article-title":"Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo","volume":"17","author":"Yu","year":"2008","journal-title":"Stem Cell Dev"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.02.014_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2005.07.004","article-title":"Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo","volume":"80","author":"Zhu","year":"2006","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.jpedsurg.2024.02.014_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.leu.2404489","article-title":"Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth","volume":"21","author":"Ramasamy","year":"2007","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jpedsurg.2024.02.014_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/17425247.2013.798640","article-title":"Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics","volume":"10","author":"Muthiah","year":"2013","journal-title":"Expet Opin Drug Deliv"},{"issue":"12","key":"10.1016\/j.jpedsurg.2024.02.014_bib30","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.jpedsurg.2019.08.023","article-title":"Novel mesenchymal stem cell delivery system as targeted therapy against neuroblastoma using the TH-MYCN mouse model","volume":"54","author":"Maniwa","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"12","key":"10.1016\/j.jpedsurg.2024.02.014_bib31","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jpedsurg.2016.09.041","article-title":"Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma","volume":"51","author":"Kimura","year":"2016","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115678","article-title":"Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma","volume":"214","author":"Cocc\u00e8","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpedsurg.2024.02.014_bib33","article-title":"Paclitaxel priming of TRAIL expressing mesenchymal stromal cells (MSCs-TRAIL) increases antitumor efficacy of their secretome","author":"Cocc\u00e8","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"10.1016\/j.jpedsurg.2024.02.014_bib34","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/ijms19082188","article-title":"Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour","volume":"19","author":"Fakiruddin","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346824000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346824000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T22:28:41Z","timestamp":1721168921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346824000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022346824000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2024.02.014","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proliferative Effects of Mesenchymal Stromal Cells on Neuroblastoma Cell Lines: Are They Tumor Promoting or Tumor Inhibiting?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2024.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}